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Over 170 million patients worldwide are chronically infected with Hepatitis C virus 
(HCV); making it a globally important infection. Dentists constantly handle sharp 
instruments infected with biological fluids and are therefore considered at high-risk 
of contracting HCV infection. Needle-stick injuries seem to be the most common 
route of exposure to blood-borne pathogens in dental practice. Moreover, 
endodontist’s constant use of sharp instruments such as endodontic files with 
limited operative vision in a small working field (i.e. root canal system) increases 
their risk of exposure to infection. The aim of this study was to review the 
epidemiology of HCV infection in dental healthcare staff and the tests required for 
its diagnosis. We also look at the protocols for dental treatment in infected 
individuals and screening and dental examination tailored for HCV patients. 
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epatitis C virus (HCV), also known as parentally 
transmitted or post transfusion non-A non-B hepatitis, 
was first identified in 1989. It is a single-stranded 
positive-sense RNA virus, enclosed in an envelope with a 
diameter of ~50 nm and is classified in a separate genus of 
Hepacivirus as the third member of the Flaviviridae family (the 
other two genera remain as Pestivirus and Flavivirus) [1, 2]. 
With more than 3% of world’s population being chronically 
infected (170 million individuals) in two decades, HCV 
infection is now considered a globally significant disease [2, 3]. 
The prevalence of HCV infection is estimated to be higher than 
human immunodeficiency virus (HIV) or even hepatitis B virus 
(HBV), in the USA. Infection with HCV is the most leading 
cause of liver transplantation worldwide. The most important 
route of transmission before 1989 was blood transfusion [4-6]. 
Mortality rate of HCV chronic infection is increasing in many 
parts of the world [5]. The prevalence of HCV infection is 
estimated to be 0.16% in Iran [7]. 
Six major genotypes (namely 1 to 6) of HCV with different 
geographically distribution have been identified so far. 
Genotypes 1, 2 and 3 are distributed worldwide with genotype 
1 accounting for 40-80% of all infected cases. Genotype 4 is 
generally found in the Middle East and Egypt, genotype 5 in 
South Africa and genotype 6 in South-East Asia [1, 8]. 
To date no HCV-effective vaccine has been developed. In 
addition, treatments are focused upon achieving a sustained 
virological response with a combination of interferon and 
ribavirin, which are usually accompanied with some side 
effects [9-11].  
The routes of disease transmission include intravenous 
drug abuse, non-protected sexual contact with multiple 
partners, iatrogenic acquisition (e.g. haemodialysis), 
accidental exposure such as needle-stick injuries (NSI) and 
vertical transmission from mother to the infant. However, in 
30-40% cases of HCV infection, the route of acquisition 
cannot be identified [12, 13]. The results of a recently 
published paper showed that although weak, there is an 
undoubted risk of HCV transmission and cross 
contamination in dental care environment, and during dental 
treatments especially when precautionary methods fail [14]. 
In recent years, more attention has been dedicated to 
educate undergraduate and postgraduate dental students to  
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Table 1. The results of the recent studies on the prevalence of HCV infection among dental health care workers (DHCWs) 
Country Population under study Test N exposed(% ) Main conclusion 
Brazil, 2009 [15] 
Dentists registered at the 
Minas Gerais Dental Council 
and working regularly in 
Belo Horizonte 
Serum anti-HCV 1302 (0.9%) 
The seroprevalence of anti-HCV 
among dentists was low. 
No occupational exposure 
conditions were associated to the 
seroprevalence of HCV. 
Brazil, 2006 [16] 
Dentists working in a town 
in the state of Sao Paulo in 
Brazil 
Serum anti-HCV; 
confirmed by PCR 135 (0.7%) 
The study alerts using standard 
precautions during professional 
dental practice to avoid 
occupational acquisition of HBV 
and HCV. 
Israel, 2009 [17] Dentists attending an annual dental conference Serum anti-HCV 296 (0.33%) 
The study did not mention HCV as 
a hazard to dental professionals. 
However, infection control 
guidelines should be strictly 
followed. 
Japan, 2008 [18] 
42 dentists, 35 dental 
hygienists, 41 dental 
assistants, 8 dental 
mechanics and 15 clerks 
Serum anti-HCV 141 (0%) Being a DHCW is not associated with HCV infection. 
Germany, 2000 [19] 
215 dentists and 108 dental 
assistants attending the 1997 
annual meeting of the 
Berliner Zahnärztekammer 
Serum anti-HCV 323 (0.3%) 
These results suggest that 
occupational transmission of HCV 
in dental settings occurs sometimes, 
but not frequently. Infection with 
HBV is 25 times higher. 
 
enhance their knowledge on prevention of blood-borne 
infections (BBI). The results of recent studies on dental students’ 
knowledge on blood-borne pathogens show that the level of 
students’ knowledge about infectious diseases and their routes of 
transmission, increases as they enter higher academic semesters 
[20, 21]. Moreover, senior students showed a more positive 
approach and less discriminating attitudes toward patients with 
BBI in comparison with junior students. It seems that using these 
programs prepares the future dentists for their up-coming 
challenges when managing patients with BBI. In addition, 
periodic mandatory attendance of dental health care workers 
(DHCW) in continuing education programs will keep them up-
to-date regarding this issue. 
Although different aspects of HIV infection has been studied 
in dentistry, there is rather low information regarding HCV 
infection in dental practice [22]. Most of the reports have been 
performed on different groups of DHCWs with variable subjects 
and methodology. Therefore, the aim of this study is to review 
the implications of HCV in endodontic practice; including the 
precautionary methods and universal cross-infection control 
protocols during daily practice as well as post-exposure strategies. 
HCV infection in DHCWs 
Dentists can be exposed to biological fluids through skin and 
mucous membranes or through percutaneous injuries, with the 
latter being the most common route of exposure. Blood exposure 
incidents, which may cause the transmission of blood-borne 
viruses, occur regularly during dental treatment procedures due 
to the close proximity to patient tissues, sharp instruments such 
as endodontic files, limited visual field in a small working area as 
well as the frequent patient movements during endodontic 
practice [23-25]. The risk of being infected with HCV after a 
single needle-stick injury is 3% [15, 20]. Using the anesthetic 
syringe and incorrect needle recapping procedures holding the 
cap with one hand and re-sheathing the needle with the other, 
are shown to be the most important causes of NSI in dentists and 
dental hygienists [26]. The risk of HCV infection following a 
blood splash is unknown but is believed to be greater if the 
source patient is positive for HCV-RNA and does not occur if 
patient is HCV-RNA negative [27]. 
The results of a nationwide study in the Netherlands 
showed that blood exposure incidents occur frequently in 
dental settings, irrespective of the type of practice. Because of 
such accidents, dental clinics need to have a protocol for 
handling blood exposure incidents according to safe working 
practice guidelines [23]. There are few reports on 
epidemiology of HCV infection in DHCWs [16, 17, 19]. 
According to our search results, no previous report has been 
performed particularly on endodontists. Although the World 
Health Organization (WHO) states that dentists are at greater risk 
of HCV infection, there are studies showing that the prevalence 
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Table 2. HCV diagnostic tests 
Anti-HCV HCV-RNA Interpretation 
Positive  Positive  Acute or chronic infection 
Positive Negative Treated infection; below detectable levels of HCV-PCR test or anti-HCV false positive (less than 1%) 
Negative Positive Early infection or chronic infection in immunosuppressed individuals 
Negative Negative Non-infected 
 
of HCV infection in this group is similar or even lower than 
that of the general population [15-19]. The prevalence of 
HCV infection in DHCWs is shown in Table 1. 
Previous papers demonstrated that the possibility of acquiring 
HCV infection is commonly related to age and work experience 
[16]. Also, a study performed in Brazil showed that anti-HCV 
seropositivity in DHCWs is significantly associated with a history 
of blood transfusion and a serologic test of HCV [15]. 
According to the results of the available reports, HCV 
infection in dentists is similar or lower than that of the general 
population. However, due to the importance of probable 
transmission of HCV in dental practice, the issue is more 
significant. Using standard precautionary methods prevent 
both dentists and their patients from being infected. 
Serologic tests 
Most HCV-infected patients (60 to 70%) are asymptomatic. 
When symptoms do occur, they are nonspecific including 
fatigue, nausea, anorexia, myalgia, arthralgia, weakness, and 
weight loss [28]. It has been demonstrated that patients’ 
medical histories are unreliable in identifying the exposure to 
blood-borne pathogens [29]. Dentists should be aware of HCV 
diagnostic tests which patients might be referred with. 
Although corresponding data shows that body fluids such as 
saliva and urine contain viral particles, routine diagnostic tests 
are still performed on serum samples [5, 30]. 
HCV diagnostic tests include the HCV antibody enzyme 
immunoassay (EIA), different generations of recombinant 
immunoblot assay (RIBA-1, 2 or 3) and quantitative HCV 
RNA-polymerase chain reaction (PCR). The most widely used 
initial assay for detecting HCV antibodies is the EIA. 
Quantitative viral load tests measure the amount of virus in 
blood. Quantitative studies provide information on initial viral 
load, viral load reduction with therapy and a sustained 
virologic response, defined as undetectable HCV by PCR, six 
months after ceasing the therapy. However, levels of HCV-RNA 
do not correlate directly with liver injury, duration of infection 
or disease severity. Table 2 explains the results and 
interpretation of HCV diagnostic tests. To analyze the liver 
function, patients might undergo some blood tests for 
assessment of liver enzymes as well as liver biopsy [28, 31-33]. 
Detection and quantification of HCV-RNA is useful in 
order to: i) diagnose a chronic HCV infection; ii) identify 
patients who need antiviral therapy; iii) monitor the virological 
responses to antiviral therapy; and iv) identify amino acid 
substitutions responsible for resistance to specific inhibitors of 
HCV viral proteins [33]. 
Recently the application of oral fluid for the detection and 
diagnosis of HCV infection has been evaluated repeatedly. 
Although most studies demonstrated that oral fluids [saliva and 
more specifically the gingival crevicular fluid (GCF)] can be used 
in HCV diagnosis, the appropriate measuring tool with reliable 
specificity is not available yet. More studies are recommended to 
design appropriate tests and validate tools [5]. 
Dental treatment for HCV-infected patients 
Living with HCV, comes along with an array of potentially serious 
consequences. Apart from physical/medical issues, social stigma is 
also an issue that viral hepatitis patients might face [22]. 
National and international guidelines such as the needle-stick 
safety act in 2001, were developed to help minimizing the risk of 
exposure to blood-borne pathogens in DHCWs including 
dental personnel [26]. While dentists and non-infected patients 
can be infected with hepatitis following inadequate sterilization 
and other precautionary methods, adequate measures should 
definitely be taken [34]. 
One of the most significant phenomena associated with 
hepatitis infected patients is DHCWs’ fear of treating them. HCV-
infected patients have significant oral health needs [35]. 
Unfortunately, the results of previous studies showed that a 
number of DHCWs prefer not to treat patients affected with HCV. 
Such a behavior is not only unethical but also induces patients to 
conceal parts of their medical history which will be detrimental for 
both patient and health care worker. 
The results of a study aiming at evaluating DHCWs 
attitudes toward caring for people with HCV performed in 
Japan showed that significant associations exist among 
DHCW’s knowledge about HCV and their self-reported 
behavior towards this population. Thirty percent of dentists 
indicated that patients with HCV should be given the last 
appointment of the day. Dentists, who reported that they 
complied with infection control guidelines, were significantly 
more likely to treat people with HCV. Additionally, 14% of 
dentists stated that they did not want to treat injecting drug 
users [36]. The results of a study performed in Australia 
showed that all dentists perform dental treatment on the 
patients with HCV even without changing their personal 
protective methods [22]. 
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Dentists should keep in mind that the best patients are 
those who inform us about their blood contamination. If we 
want them to inform us of the issue, our behavior should be 
non-discriminative and understanding. Our practice should be 
the same for all patients as they may carry a blood-borne virus 
unknown to us and/or themselves. 
Dental check-ups for HCV infected patients 
Previous reports showed that infection with HCV might 
accompany a number of extrahepatic conditions. Mixed 
cryoglobulinemia, glomerulonephritis, polyarteritis nodosa, 
rashes, renal disease, neuropathy and lymphoma are strongly 
associated with HCV infection. In addition, some oral 
conditions have been found to be related to HCV [37, 38]. 
There are just few reports on oral health of HCV infected 
patients, mostly performed in developed countries. The results of 
all these investigations show serious oral health needs in this 
group of patients [39, 40]. There are also oral mucosa conditions 
related to HCV infection. Reports show that oral lichen planus 
(OLP) is also associated with virus infection in some parts of the 
world [41, 42]. Replication of viral particles in salivary glands as 
well as antiviral therapies might cause symptoms similar to 
Sjogren’s syndrome and hyposalivation [43]. Besides, other 
conditions related to HCV infection such as oral cancer and 
pemphigus need to be assessed more precisely. 
Dental problems might delay the administration of HCV 
treatments. Plus, dental problems might worsen after applying 
antiviral treatments because of their side effects [44]. Patients 
with HCV infection should be routinely screened for oral health 
problems. Dentists should also be aware of probable and 
common conditions in the oral mucosa in this population and 
should meticulously assess their patients. 
Conclusion 
HCV infection is a condition with global impact. Along with 
common routes of transmission, DHCWs are always suspected 
whether to infect their patients or get infected. Although there 
are reports informing that dentists and oral surgeons have 
infected their patients with HBV during dental treatments, to 
date there is no similar report on HCV. However, available 
reports imply such threat in dentistry if universal infection 
control strategies are not adhered to. Further studies are also 
needed to assess the prevalence of HCV among DHCWs. 
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